Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A way to ...
Lerodalcibep-liga, a once-monthly PCSK9 inhibitor, significantly reduces LDL-C in hypercholesterolemia, including HeFH, with ...
The Martin/Hopkins method of low-density lipoprotein (LDL) cholesterol assessment is more accurate that the usual calculation method, according to an analysis of the FOURIER trial. Among FOURIER ...
Please provide your email address to receive an email when new articles are posted on . Cholesterol increases significantly in infants during the first year of life; however, high-sugar formula ...
Hosted on MSN
Enlicitide: New Drug Cuts LDL Cholesterol By 60 Percent, Offers Fresh Hope For Heart Health
High levels of low-density lipoprotein cholesterol (LDL-C), commonly called "bad" cholesterol, continue to be a leading modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD) ...
A new study has drawn attention to inaccurate measurement of LDL-cholesterol levels in some patients with current assays, which could lead to incorrect therapeutic approaches. The patient groups most ...
Measuring the number of years an individual is exposed to high LDL-cholesterol levels can better predict cardiovascular events than a static measure of LDL cholesterol levels in early middle age, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback